BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8186951)

  • 1. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.
    Papp MI; Lantos PL
    Brain; 1994 Apr; 117 ( Pt 2)():235-43. PubMed ID: 8186951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.
    Inoue M; Yagishita S; Ryo M; Hasegawa K; Amano N; Matsushita M
    Acta Neuropathol; 1997 Jun; 93(6):585-91. PubMed ID: 9194897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).
    Papp MI; Kahn JE; Lantos PL
    J Neurol Sci; 1989 Dec; 94(1-3):79-100. PubMed ID: 2559165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendroglial and neuronal inclusions in multiple system atrophy.
    Costa C; Duyckaerts C
    Curr Opin Neurol; 1993 Dec; 6(6):865-71. PubMed ID: 8293161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy.
    Papp MI; Lantos PL
    J Neurol Sci; 1992 Feb; 107(2):172-82. PubMed ID: 1314292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oligodendroglial inclusions, a marker of multisystemic atrophies].
    Costa C; Duyckaerts C; Cervera P; Hauw JJ
    Rev Neurol (Paris); 1992; 148(4):274-80. PubMed ID: 1332174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatonigral degeneration, olivopontocerebellar atrophy and "atypical" Pick disease.
    Horoupian DS; Dickson DW
    Acta Neuropathol; 1991; 81(3):287-95. PubMed ID: 1711756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple system atrophy.
    Quinn N; Wenning G
    Curr Opin Neurol; 1995 Aug; 8(4):323-6. PubMed ID: 7582051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.
    Ozawa T; Paviour D; Quinn NP; Josephs KA; Sangha H; Kilford L; Healy DG; Wood NW; Lees AJ; Holton JL; Revesz T
    Brain; 2004 Dec; 127(Pt 12):2657-71. PubMed ID: 15509623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy.
    Nakamura S; Kawamoto Y; Nakano S; Akiguchi I
    Clin Neuropathol; 2000; 19(2):51-6. PubMed ID: 10749284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple system atrophy.
    Quinn N; Wenning G
    Br J Hosp Med; 1994 May 4-17; 51(9):492-4. PubMed ID: 7921508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodendroglial and neuronal cytoplasmic inclusions in multisystem atrophy.
    Horoupian DS
    Prog Brain Res; 1992; 94():423-8. PubMed ID: 1287727
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical expression of microtubule-associated protein 5 (MAP5) in glial cells in multiple system atrophy.
    Arai N; Nishimura M; Oda M; Morimatsu Y; Ohe R; Nagatomo H
    J Neurol Sci; 1992 May; 109(1):102-6. PubMed ID: 1517758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective nuclear shrinkage of oligodendrocytes lacking glial cytoplasmic inclusions in multiple system atrophy: a 3-dimensional volumetric study.
    Uyama N; Uchihara T; Mochizuki Y; Nakamura A; Takahashi R; Mizutani T
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1084-91. PubMed ID: 19918120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report.
    Hughes AJ; Daniel SE; Lees AJ
    Mov Disord; 1991; 6(4):342-6. PubMed ID: 1758453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of neuronal degeneration of multiple system atrophy].
    Yoshida M; Sone M
    Brain Nerve; 2009 Sep; 61(9):1051-60. PubMed ID: 19803404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitinated alpha B-crystallin in glial cytoplasmic inclusions from the brain of a patient with multiple system atrophy.
    Tamaoka A; Mizusawa H; Mori H; Shoji S
    J Neurol Sci; 1995 Apr; 129(2):192-8. PubMed ID: 7608736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on argyrophilic inclusions of multisystem atrophy (Oppenheimer)].
    Iwabuchi K; Kosaka K; Haga C; Tuchiya K; Amano N; Itoh K; Yagishita S; Mizutani Y
    No To Shinkei; 1991 Jun; 43(6):561-8. PubMed ID: 1654964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Minimal change" multiple system atrophy.
    Wenning GK; Quinn N; Magalhăes M; Mathias C; Daniel SE
    Mov Disord; 1994 Mar; 9(2):161-6. PubMed ID: 8196676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
    Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.